Basic Information
Basic information for NR2F1-AS1-224-31aa
Peptide Name NR2F1-AS1-224-31aa
Genome Position chr5:93581114-93581206[-]
Species Human
Peptide Sequence MARRRLGVAGAPCPRPYAQINAQTRSRLLVS
Peptide Length 31
Unique No (NR2F1-AS1-201-31aa-2,NR2F1-AS1-203-31aa,NR2F1-AS1-204-31aa,NR2F1-AS1-215-31aa-2,NR2F1-AS1-220-31aa-2,NR2F1-AS1-223-31aa-3,NR2F1-AS1-228-31aa,NR2F1-AS1-229-31aa,NR2F1-AS1-236-31aa,NR2F1-AS1-250-31aa,NR2F1-AS1-257-31aa,NR2F1-AS1-258-31aa,NR2F1-AS1-263-31aa-2,NR2F1-AS1-267-31aa-2,NR2F1-AS1-272-31aa-2)
Grand Average of Hydropathicity -0.2903
Relative Molecular Mass 3950.48
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000654055;NR2F1-AS1-224
Transcript Length 3530
Coding Ability 0.3567
DNA Sequence Corresponding to Peptide ATGGCGAGGAGGCGACTGGGGGTAGCAGGGGCTCCTTGCCCTCGTCCCTATGCCCAAATAAACGCGCAAACGCGCTCCCGTCTTCTGGTCAGT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :